期刊
PHARMACEUTICAL CHEMISTRY JOURNAL
卷 57, 期 2, 页码 214-217出版社
SPRINGER
DOI: 10.1007/s11094-023-02885-2
关键词
5-aryl(hetaryl)methylidene-2; 4; 6-pyrimidine-2; 6(1H; 3H; 5H)-triones; 5-(2-chloropropylidene)-2; antileprotic activity; antituberculotic activity; minimum inhibitory and bactericidal concentrations
The effect of 5-aryl(hetaryl)methylidene-2,4,6-pyrimidine-2,4,6(1H,3H,5H)-triones and 5-(2-chloropropylidene)-2,4,6-pyrimidine-2,4,6(1H,3H,5H)-triones on the viability of M. tuberculosis H(37)Rv strain was investigated. Minimum inhibitory and bactericidal concentrations, as well as acute toxicity in mice, were determined. Compounds XIII, XIV, XVII, and XIX exhibited the strongest antituberculotic activity against M. tuberculosis H(37)Rv, suggesting their potential for further development as effective antituberculotic drugs.
The effect of 5-aryl(hetaryl)methylidene-2,4,6-pyrimidine-2,4,6(1H,3H,5H)-triones and 5-(2-chloropropylidene)-2,4,6-pyrimidine-2,4,6(1H,3H,5H)-triones on the viability of laboratory strain M. tuberculosis H(37)Rv was studied. The minimum inhibitory and bactericidal concentrations and the acute toxicity in mice have been determined. Compounds XIII, XIV, XVII, and XIX had the greatest antituberculotic activity for M. tuberculosis H(37)Rv, indicating they were promising for further studies aimed at creating effective antituberculotic drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据